F783-0385 Screening compound: N-{3-[CYCLOHEXYL(METHYL)AMINO]PROPYL}-2-[(4-ACETAMIDOPHENYL)METHYL]-1H-1,3-BENZODIAZOLE-5-CARBOXAMIDE

F783-0385 Screening compound: N-{3-[CYCLOHEXYL(METHYL)AMINO]PROPYL}-2-[(4-ACETAMIDOPHENYL)METHYL]-1H-1,3-BENZODIAZOLE-5-CARBOXAMIDE
F783-0385 Screening compound: N-{3-[CYCLOHEXYL(METHYL)AMINO]PROPYL}-2-[(4-ACETAMIDOPHENYL)METHYL]-1H-1,3-BENZODIAZOLE-5-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound F783-0385
N-{3-[CYCLOHEXYL(METHYL)AMINO]PROPYL}-2-[(4-ACETAMIDOPHENYL)METHYL]-1H-1,3-BENZODIAZOLE-5-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F783-0385

Molecular Formula

C27H35N5O2 (C27 H35 N5 O2)

Compound Name

N-{3-[CYCLOHEXYL(METHYL)AMINO]PROPYL}-2-[(4-ACETAMIDOPHENYL)METHYL]-1H-1,3-BENZODIAZOLE-5-CARBOXAMIDE

IUPAC name

N-{3-[cyclohexyl(methyl)amino]propyl}-2-[(4-acetamidophenyl)methyl]-1H-13-benzodiazole-5-carboxamide

SMILES

CC(Nc1ccc(Cc2nc(cc(cc3)C(NCCCN(C)C4CCCCC4)=O)c3[nH]2)cc1)=O

InChI

InChI=1S/C27H35N5O2/c1-19(33)29-22-12-9-20(10-13-22)17-26-30-24-14-11-21(18-25(24)31-26)27(34)28-15-6-16-32(2)23-7-4-3-5-8-23/h9-14,18,23H,3-8,15-17H2,1-2H3,(H,28,34)(H,29,33)(H,30,31)

InChI Key

DXVKTUUUEAVJIG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14966719

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

461.61

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.564

Distribution Coefficient, logD

1.039

Water Solubility, LogSw

-3.72

Polar Surface Area

70.803

Acid Dissociation Constant (pKa)

10.78

Base Dissociation Constant (pKb)

9.92

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.40

F783-0385 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

GPCR Targeted Library (31838 compounds)

Lipid Metabolism Library (9174 compounds)

PLpro Library (6343 compounds)

Protein-Protein Interaction Library (218420 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cardiovascular
  • Metabolic
  • Antiviral
  • Infections
  • Immune system
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F783-0385 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F783-0385?
Check Price and Availability of F783-0385, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F783-0385 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F783-0385
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F783-0385
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F783-0385 available by request